Skip to content

Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs

Impact Des Performances Cognitives et métacognitives Sur l'Apprentissage de Connaissances Lors de la réalisation de Programmes d'éducation thérapeutique

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04590300
Acronym
MetaCOGNITION
Enrollment
108
Registered
2020-10-19
Start date
2020-10-06
Completion date
2022-12-31
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Schizophrenia

Brief summary

People with schizophrenia and bipolar disorder display alterations in cognition and metacognition. These alterations may have an impact on learning during therapeutic education programs.

Detailed description

Patient Therapeutic Education (FTE) is defined as a practice to help patients to acquire or maintain the skills needed to best manage their lives with a chronic disease. FTE includes organized awareness, information, learning and psychological and social assistance about the disease, prescribed treatments, various treatments offered, as well as information on organization of the global health system, and health behaviours. Performed by health professionals trained in this practice, FTE is intended to help patients and their close relatives and to understand their pathology, their treatments, collaborate with health care teams, and maintain or improve their quality of life. It aims to produce a complementary therapeutic effect of other health care interventions

Interventions

OTHERQUESTIONNAIRES

1 questionnaire at the beginning of the study, before FTE program 1 questionnaire at the end of FTE

Sponsors

Centre Hospitalier Charles Perrens, Bordeaux
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consent to participate in the study, * Suffering from a chronic condition for which an therapeutic patient education (TEP) program is proposed. * Mastering the French language. * Be a beneficiary of health insurance

Exclusion criteria

* Poor understanding of instructions that make it impossible to consent or assess * Neurodegenerative disease

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of cognitive impairments on knowledge acquired through a therapeutic education program with Montreal Cognitive Assessment (MoCA)1 yearassess the impact of possible cognitive impairments on knowledge acquired through a therapeutic education program Minimum value = 0 & Maximum value = 30 Score \< 26 is considered as abnormal
Evaluation of metacognitive impairments on knowledge acquired through a therapeutic education program with Subjective Scale To Investigate Cognition in Schizophrenia (SSTICS)1 yearassess the impact of possible metacognitive impairments on knowledge acquired through a therapeutic education program Minimum value 21

Secondary

MeasureTime frameDescription
assess the impact of self esteem acquired through a therapeutic education program with Rosenberg scale1 yearassess the evolution in self-esteem following this program.
assess the impact of level of anxiety, acquired through a therapeutic education program with State-Trait-Anxiety Inventory (Forme Y) (STAI-Y) questionnaire1 yearassess the evolution in level of anxiety following this program.
assess the impact of depressive symptomatology acquired through a therapeutic education program with Center for Epidemiologic Studies-Depression (CES-D) scale1 yearassess the evolution in depressive symptoms following this program.
assess the impact of literacy on knowledge acquired through a therapeutic education program with Rapid Estimate for Adult Literacy in Medicine (REALM-R) questionnaire1 yearassess the evolution in quality of life following this program.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026